MentionFox
Home › funding signals › Eldec Pharmaceuticals, Inc.
Form D · on the record

Eldec Pharmaceuticals — $200K Form D filing, February 2026

Eldec Pharmaceuticals, Inc. filed a Form D with the Securities and Exchange Commission on 2026-02-12.

Eldec Pharmaceuticals, Inc. filed a Form D notice of an exempt securities offering with the SEC on February 12, 2026. The filing reports $200K sold. Its industry group is Pharmaceuticals. It names Robert Schotzinger (Executive Officer, Director), Robert Tarran (Executive Officer, Director) (SEC Form D, February 12, 2026).

5 more Pharmaceuticals raises within 90 days of this one ↓

Sell to companies like Eldec Pharmaceuticals, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.

Opens in a new tab. No signup.

Key facts

Run the free check on Eldec Pharmaceuticals, Inc. →

Eldec Pharmaceuticals, Inc.

New Form D on file · 2026-02-12 · the record

$200K
raise on the record
D
filing
1
investors in
NORTH CAROLINA
based
Open the record →

What the record says

FilingForm D
Filed2026-02-12
Industry groupPharmaceuticals
Entity typeCorporation
Incorporated inDELAWARE
BasedCHAPEL HILL, NORTH CAROLINA
CIK2110508
Accession0002110508-26-000001

Pitching, partnering or investing alongside them? See who really runs and owns Eldec Pharmaceuticals, Inc.

Watch Eldec Pharmaceuticals, Inc.

Free to see. No signup.

Keep reading

More on the people and the money behind Eldec Pharmaceuticals, Inc., from the filings we hold.

More raises like this

Pharmaceuticals raises filed within 90 days of this one, largest first.

What do you want to do with Eldec Pharmaceuticals, Inc.?

Get the full cited report on Eldec Pharmaceuticals, Inc.

What the filing shows about Eldec Pharmaceuticals, Inc.

  • 1 investor had already put money in when it filed.
  • The filing names 2 people as officers, directors or promoters.

Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.

Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)

A Full Report on Eldec Pharmaceuticals, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

See a sample report

What the filing says

  • Offered: $1,500,000. Sold: $200,000. Left to sell: $1,300,000. (filing)
  • Investors: 1 had already invested. (filing)
  • Date of first sale: February 11, 2026. (filing)
  • Types of securities: Debt; Options, warrants or other rights to acquire another security; Securities to be acquired on exercise of an option, warrant or other right. (filing)
  • Item 16: the filing reports that none of the proceeds goes to executive officers, directors or promoters. It adds: “Proceeds will be used for working capital, which may include normal compensation to executive officers.” (filing)

This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.

Order the Full Report on Eldec Pharmaceuticals, Inc. See pricing

Pharmaceuticals · by week
This raise, $200K, filed week of Feb 9

Trailing twelve months. 157 filings in Pharmaceuticals, totalled by week. The dot is this raise, $200K, on the same scale — one filing against the whole group's total, so it sits low by construction.

Want the whole picture on Eldec Pharmaceuticals, Inc.?

What the filing shows about Eldec Pharmaceuticals, Inc.

  • 1 investor had already put money in when it filed.
  • The filing names 2 people as officers, directors or promoters.

Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.

Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)

A Full Report on Eldec Pharmaceuticals, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on Eldec Pharmaceuticals, Inc. covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    1 cited source found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on EchoStar: the verdict, 17 sections, 63 cited sources, built 2026-10-21A real finished report, first screen. Opens in a new tab.

The full profile

Checking your access…

Is this you?

If you're behind Eldec Pharmaceuticals, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.

Sourced from the filing index on sec.gov.

RSS

Tools for this story

Each opens in a new tab, filled in for Eldec Pharmaceuticals, Inc.. With no account yet, you sign up free and land on the result.

Share this page

Just raised? Share it.

Eldec Pharmaceuticals, Inc.: Raised $200K, Form D filed 2026-02-12

Cite this page

Permanent URL: https://mentionfox.com/funding/eldec-pharmaceuticals-inc-form-d-26000001
Last updated 2026-10-25
Primary record: SEC filing 1 · SEC filing 2
Eldec Pharmaceuticals raised $200K — SEC Form D filing, February 2026. MentionFox, 2026-10-25. https://mentionfox.com/funding/eldec-pharmaceuticals-inc-form-d-26000001